Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 7K9Z | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with the Fab fragments of neutralizing antibodies 298 and 52 | |
| 7XA7 | A0A7D7FA76 | Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2 | |
| 7XA7 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2 | |
| 7L7E | 7L7E | Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and AZD1061 | |
| 7L7E | P0DTC2 | Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and AZD1061 | |
| 7L7D | P0DTC2 | Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibody AZD8895 | |
| 7L7D | 7L7D | Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibody AZD8895 | |
| 7B62 | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein N-terminal domain in complex with biliverdin | |
| 7KN3 | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody S-B8 Fab | |
| 7KN3 | 7KN3 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody S-B8 Fab | |
| 7KN4 | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody S-E6 Fab | |
| 7KN4 | 7KN4 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody S-E6 Fab | |
| 7T7B | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing antibody ADI-62113 Fab | |
| 7T7B | 7T7B | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing antibody ADI-62113 Fab | |
| 8CWU | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 1-21 | |
| 8CWU | 8CWU | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 1-21 | |
| 8CWV | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 2-31 and a human antibody CC12.1 Fab | |
| 8CWV | 8CWV | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 2-31 and a human antibody CC12.1 Fab | |
| 7SBU | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a highly potent antibody J08 Fab | |
| 7SBU | 7SBU | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a highly potent antibody J08 Fab | |
| 8ELO | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with antibody CC12.1 Fab and nanobody Nb-C4-225 | |
| 8ELO | 8ELO | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with antibody CC12.1 Fab and nanobody Nb-C4-225 | |
| 8ELP | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with antibody CC12.1 Fab and nanobody Nb-C4-240 | |
| 8ELP | 8ELP | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with antibody CC12.1 Fab and nanobody Nb-C4-240 | |
| 8ELQ | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with antibody CC12.1 Fab and nanobody Nb-C4-255 | |
| 8ELQ | 8ELQ | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with antibody CC12.1 Fab and nanobody Nb-C4-255 | |
| 7JMW | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with cross-neutralizing antibody COVA1-16 Fab | |
| 7JMW | 7JMW | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with cross-neutralizing antibody COVA1-16 Fab | |
| 7LM8 | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with two cross-neutralizing antibodies CV38-142 and COVA1-16 Fabs isolated from COVID-19 patients | |
| 7LM8 | 7LM8 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with two cross-neutralizing antibodies CV38-142 and COVA1-16 Fabs isolated from COVID-19 patients | |
| 7XS8 | 7XS8 | Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P5S-1H1 Fab | |
| 7XS8 | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P5S-1H1 Fab | |
| 7WNB | 7WNB | Crystal structure of SARS-CoV-2 spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab | |
| 7WNB | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab | |
| 7WN2 | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain (RBD) in complex with NCV2SG53 Fab | |
| 7WN2 | 7WN2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain (RBD) in complex with NCV2SG53 Fab | |
| 7X2H | 7X2H | Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with 6-2C Fab | |
| 7X2H | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with 6-2C Fab | |
| 6M0J | Q9BYF1 | Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 | |
| 6M0J | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 | |
| 8SIQ | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibodies CC25.36 and CV38-142 Fab | |
| 8SIQ | 8SIQ | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibodies CC25.36 and CV38-142 Fab | |
| 8SIR | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC25.54 Fab | |
| 8SIR | 8SIR | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC25.54 Fab | |
| 8SIS | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.2 Fab | |
| 8SIS | 8SIS | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.2 Fab | |
| 8SIT | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.24 Fab | |
| 8SIT | 8SIT | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.24 Fab | |
| 8H5T | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with neutralizing nanobody Nb-015 | |
| 8H5T | 8H5T | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with neutralizing nanobody Nb-015 |
